FBT ETF (First Trust NYSE Arca Biotechnology Index Fund) is managed by First Trust Portfolios (US) with $2.29B in net assets. FBT expense ratio is 0.54%, holding 31 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2006-06-19.

FBT performance shows a YTD return of 0.41%. The 1-year return is 19.17% and the 5-year return is 4.57%.

FBT top holdings include Gilead Sciences Inc (4.2%), Moderna therapeutics (4.1%), Alkermes Plc (4.0%), Amgen Inc. (3.9%), Halozyme Therapeutics Inc (3.7%). View all FBT holdings, sector breakdown, or dividend history.

FBT can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBT alternatives are available via the screener, along with tax-loss harvesting opportunities.